Study To Find The effect of Astang Ghrita in Attention Deficit Hyperactive disorder

Clinical Study To Evaluate The Efficacy of Astang Ghrita In Attention Deficit Hyperactive Disorder - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/113536

Enrollment

Registered

2026-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children Of Either Sex 2. Children Of Age Group 6-18 Year 3. Children Diagnosed To Be Suffering From ADHD As Per DSM V Criteria 4. Parents/Guardian Willing To Be Give Informed Written Consent To Participant In The The Study

Exclusion criteria

Exclusion criteria: 1. PATIENT AGED BELOW 5 YEARS AND ABOVE 18 YEARS 2. PATIENTS HAVING MENTAL RETARDATION, CEREBRAL PALSY, SEIZURES,EPILEPSY. 3. PATIENTS HAVING PRESENCE OF OTHER ORGANIC OR PSCHOTIC NEUROLOGICAL DISORDER. 4. PATIENTS HAVING HEARING AND VISUAL IMPAIRMENT. 5. PATIENTS HAVING ACUTE AND CHRONIC SYSTEMIC ILLNESS SUCH AS RENAL DISEASES,HEPATIC DYSFUNCTION, JUVENILE DIABETES ETC. 6. PATIENTS HAVING ANY OTHER CONGENITAL DISORDERS. 7. PATIENT HAVING CHRONIC ADHD

Design outcomes

Primary

Measure	Time frame
Improvement In Symptoms Of ADHD Timepoint: 1 Year	—

Secondary

Measure	Time frame
The Study Will Be Cost Effective,Safe Drug With Lesser Side Effects.Timepoint: 1 Year	—

Countries

India

Contacts

Public ContactAayushi Shrivastav

PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN

pwadhwa13@gmail.com81059 38269

Outcome results